Open original FDA record ↗Recall record
- FDA identifier
- Z-2124-2012
- Company in FDA record
- Iris Diagnostics
- FDA classification date
- Aug 1, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class III
Reason stated in the source
The firm recalled after it received complaints of IRISpec CA/CB two part Urine Chemistry Control, 101131-12, where the nitrite results read negative for the part B control, which should be positive.
Source facts
- Action
- The firm initiated the recall on 07/09/12 by sending out a Medical Device Recall notification to customers via e-mail. The recall notification identified the affected product, reason for recall, and instructions on the recall. Customers were to confirm how many sets of unopened or partially opened IRISpec CA/CB that was in their inventory, dispose of the affected product, and provide written confirmation of the product's disposition. The letter also stated that Iris Diagnostics would replace any unused inventory that was returned at no charge to the customer. Contact information for the recall was also provided. The communications also included a fax response sheet for return/replacement.
- Initiated
- 2012-07-09
- Root cause
- Nonconforming Material/Component
- Terminated
- 2014-01-27
- Distribution
- Nationwide Distribution
- Recall number
- Z-2124-2012
- Recall status
- Terminated
- CDRH record ID
- 110976
- FDA classified
- 2012-08-01
- Recall event number
- 62555